Found 119 articles for: "Alopecia areata"
Reversal of Stress-Associated Alopecia
March 2023 | Volume 22 | Issue 3 | Case Reports | 300 | Copyright © March 2023
Novel coronavirus SARS-CoV-2, designated as COVID-19 by the World Health Organization (WHO) on February 11, 2020, is one of the highly pathogenic β-coronaviruses that infects humans.1 ...
Read MoreUtilization Management Barriers Among Patients With Cicatricial Alopecia
March 2023 | Volume 22 | Issue 3 | Features | 312 | Copyright © March 2023
Citation: Rypka K, Pathoulas J, Wharton K, et al. Utilization management barriers among patients with cicatricial alopecia. J Drugs Dermatol. 2023;22(3):312-314. doi:10.36849/JDD.684...
Read MoreTopical Minoxidil Adherence in Patients With Alopecia
March 2023 | Volume 22 | Issue 3 | Original Article | 252 | Copyright © March 2023
Background: Non-adherence to topical minoxidil in alopecia patients is a barrier to efficacy. Understanding patient factors associated with adherence and non-adherence may provide act...
Read MoreA Review of the Challenges and Nuances in Treating Rosacea in Asian Skin Types Using Cleansers and Moisturizers as Adjuncts
January 2023 | Volume 22 | Issue 1 | Original Article | 45 | Copyright © January 2023
Background: Rosacea is primarily an inflammatory disease of facial skin associated with impaired skin barrier function. While it is commonly thought of as a Caucasian person's disease...
Read MoreExamining the Potential for Koebnerization and Disease Precipitation in Cicatricial Alopecias
January 2023 | Volume 22 | Issue 1 | Original Article | 29 | Copyright © January 2023
The treatment of primary scarring alopecias is challenging and patients may be susceptible to koebnerization. This predisposes cicatricial alopecia patients to worsening of their disease following pro...
Read MoreAn Analysis of Alopecia Related Content on Instagram and TikTok
December 2022 | Volume 21 | Issue 12 | Original Article | 1316 | Copyright © December 2022
Background: Social media platforms continue to grow in popularity and have become common sources of medical information and education for patients struggling with hair loss.
Read More Off-Label Uses of JAK Inhibitors in Dermatology
October 2022 | Volume 21 | Issue 10 | Features | 1143 | Copyright © October 2022
The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway is a crucial component of immune function, and JAK inhibitors allow dermatologists to regulate this pathway in ce...
Read MoreJAK Inhibitor Safety Compared to Traditional Systemic Immunosuppressive Therapies
December 2022 | Volume 21 | Issue 12 | Original Article | 1298 | Copyright © December 2022
Dermatologists treating atopic dermatitis are interested in the safety profile of the recently available JAK inhibitors, upadacitinib and abrocitinib, especially after they received boxed safety warni...
Read MoreRefractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy
December 2022 | Volume 21 | Issue 12 | Case Reports | 1366 | Copyright © December 2022
Background: In the last several years, oral tofacitinib has become an increasingly utilized off-label treatment option for immune-mediated skin conditions such as alopecia areata (AA)...
Read MoreA Case of Successful Management of Adult-Onset Linear IgA Bullous Disease With Sulfasalazine During the COVID-19 Pandemic
December 2022 | Volume 21 | Issue 12 | Case Reports | 1355 | Copyright © December 2022
Linear IgA bullous disease (LABD) is a rare, acquired, autoimmune, pruritic, and blistering skin condition. Dapsone is a first line treatment option, however, there are limited options if this fails, ...
Read MoreEvaluating the Efficacy of Platelet Rich Plasma and 1550 nm Fractional Laser in Combination and Alone for the Management of Androgenetic Alopecia
November 2022 | Volume 21 | Issue 11 | Original Article | 1166 | Copyright © November 2022
Androgenetic alopecia (AGA) in men and women is the most common cause of hair loss. Affected individuals may experience psychological distress and social withdrawal. Current treatment options for AGA,...
Read MoreComparison of Pediatric Dermatology Conditions Across Telehealth and In-Person Visits During the COVID-19 Pandemic
November 2022 | Volume 21 | Issue 11 | Features | 1260 | Copyright © November 2022
Understanding the utility of virtual visits in pediatric dermatology practice has become increasingly important in the telehealth era. We compared the conditions diagnosed in pediatric dermatology bet...
Read MoreThe Role of Antihistamines and Dupilumab in the Management of Alopecia Areata: A Systematic Review
October 2022 | Volume 21 | Issue 10 | Original Article | 1070 | Copyright © October 2022
Background: Approximately 30% to 40% of alopecia areata (AA) patients have atopic dermatitis. Studies suggest that antihistamines and dupilumab may be effective treatments; however, t...
Read MoreA Survey of Patient Attitudes Towards Topical Minoxidil in the Treatment of Hair Loss
October 2022 | Volume 21 | Issue 10 | Editorials | 1140 | Copyright © October 2022
Hair loss, specifically androgenetic alopecia (AGA), is a common outpatient dermatology complaint. AGA occurs in men and women, results from the effect of dihydrotestosterone miniaturizing scalp folli...
Read MoreSystemic Medications Associated With Hair Texture Changes
September 2022 | Volume 21 | Issue 9 | Original Article | 989 | Copyright © September 2022
Background: In addition to hair loss, alterations in hair texture can be a worrisome side effect of certain medications yet are seldom reported and poorly characterized.
Read More Rituximab-Induced Alopecia Universalis in a Patient With Bullous Pemphigoid
August 2022 | Volume 21 | Issue 8 | Case Reports | 894 | Copyright © August 2022
Alopecia areata is a CD8+ T-lymphocyte driven autoimmune disorder leading to reversible hair loss. While most commonly presenting as isolated well-demarcated non-cicatricial alopecic patches on the sc...
Read MoreInternational Dermatology Outcome Measures (IDEOM): Report from the 2021 Annual Meeting
August 2022 | Volume 21 | Issue 8 | Original Article | 867 | Copyright © August 2022
Background: International Dermatology Outcome Measures (IDEOM) is a non-profit organization founded in 2013. It is composed of researchers and stakeholders who work to develop evidenc...
Read MoreCoconut, Castor, and Argan Oil for Hair in Skin of Color Patients: A Systematic Review
July 2022 | Volume 21 | Issue 7 | Original Article | 751 | Copyright © July 2022
Coconut, castor, and argan oils are popular commercial hair oils culturally rooted in current and historical Indian and African heritages. Dermatologists treating hair and scalp conditions often face ...
Read MoreA Long-Term Study of the Safety and Efficacy of a Nutraceutical Supplement for Promoting Hair Growth in Perimenopausal, Menopausal, and Postmenopausal Women
July 2022 | Volume 21 | Issue 7 | Original Article | 783 | Copyright © July 2022
The prevalence of female hair loss and hair thinning increases with advancing age and is most common among post-menopausal women. Recent statistics show that by age 60, an estimated 80% of women exper...
Read MoreRetrospective Study of Covid Related Hair Loss
July 2022 | Volume 21 | Issue 7 | Original Article | 724 | Copyright © July 2022
The Novel Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus two and primarily affects the epithelium of the airways. Multiple cutaneous manifestations of COVID-...
Read More